Skip to main content
An official website of the United States government

Contact the NExT Program

For any questions, comments, or feedback around the NCI Experimental Therapeutics (NExT) program, or to inquire more about the the application submission process, please email NCINExTinfo@mail.nih.gov.

The NExT Program offers a 30 minute program consultation to applicants. To request an appointment, please email NCINExTinfo@mail.nih.gov.

Contact Information

  • Phone (main): 800-422-6237
  • Email: NCINExTinfo@mail.nih.gov
  • Mail addresses and locations: We have the following four locations:
    • Bethesda Campus:
      National Cancer Institute
      9000 Rockville Pike
      Bethesda, MD 20892
    • Shady Grove Campus:
      National Cancer Institute
      9609 Medical Center Dr
      Rockville, MD 20850
    • DCTD Office of the Director:
      National Cancer Institute
      Division of Cancer Treatment and Diagnosis
      Office of the Director
      31 Center Drive Suite 3A44
      Bethesda, Maryland 20892
    • Frederick Campus:
      National Cancer Institute
      1050 Boyles St.
      Frederick, MD 21702

Drug Development Consultation

Prior to reaching out for a general NExT Program Consultation, potential applicants are highly encouraged to request a consultation with the NCI's Drug Development Consultation Group.  A typical consultation session lasts around one hour, which consists of a 15-20 minute presentation from the applicant, followed by a question, answer, and feedback session from the group.

The consultation is two-fold:

  • allows investigators to receive helpful feedback on their proposal, including some potential strategies for crafting their NExT applications
  • allows NCI staff to evaluate and understand where the proposal and specific requests may fit within NCI's current portfolio

If you are interested, please schedule a consultation with the Drug Development Consultation group.

  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Contact the NExT Program was originally published by the National Cancer Institute.”

Email